{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-059372","form_type":"8-K","ticker":"HSDT","cik":"0001610853","company_name":"Solana Co","filed_at":"2024-05-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.248438+00:00","generated_at":"2026-06-02T06:05:01.977500+00:00","sec_items":["1.01","3.03","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Helius Medical prices $6.4M public offering of stock and warrants","bullets":["Offering consists of 804,999 shares, 2,047,222 pre-funded warrants, and Series A/B warrants for up to 5.7M shares.","Gross proceeds of ~$6.4M before fees; closed May 9, 2024; proceeds for working capital and operations.","Regains compliance with Nasdaq $2.5M stockholders' equity minimum after offering; subject to ongoing monitoring.","Placement agent: Craig-Hallum; lock-up agreements for 90 days for executives and directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-059372","json":"https://secwatch.observer/filing/0001104659-24-059372.json","markdown":"https://secwatch.observer/filing/0001104659-24-059372.md","text":"https://secwatch.observer/filing/0001104659-24-059372.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1610853/000110465924059372/0001104659-24-059372-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1610853/000110465924059372/tm2411553d9_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T06:05:01.977500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"bc30aa27b5cc5510b01daa5a04b9d9e49f5aa70a","claim":"Solana Co entered into Placement Agency Agreement with Craig-Hallum Capital Group LLC valued at approximately $6.4 million (effective 2024-05-06).","evidence_excerpt":"On May 6, 2024, Helius Medical Technologies, Inc., (the “Company”), entered into a placement agency agreement (the “Placement Agency Agreement”) with Craig-Hallum Capital Group LLC (the “Placement Agent”) for the purchase and sale, in a registered public offering by the Company (the “Public Offering”) of 704,999 shares of its Class A common stock, par value $0.001 per share (“Common Stock”) and 2,147,222 pre-funded warrants, each to purchase one share of Common Stock at an exercise price of $0.001 per share (the “Pre-funded Warrants”) together with accompanying Series A Warrants to purchase up to 2,852,221 shares of its Common Stock (“Series A Warrants”) and Series B Warrants to purchase up to 2,852,221 shares of its Common Stock (“Series B Warrants”, and together with the Series A Warrants, the “Public Warrants”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1610853/000110465924059372/0001104659-24-059372-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Craig-Hallum Capital Group LLC"},{"label":"Value","value":"approximately $6.4 million"},{"label":"Effective","value":"2024-05-06"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}